A simplified extracorporeal photopheresis procedure based on single high-dose ultraviolet A light irradiation shows similar in vitro efficacy
- PMID: 33300629
- DOI: 10.1111/trf.16209
A simplified extracorporeal photopheresis procedure based on single high-dose ultraviolet A light irradiation shows similar in vitro efficacy
Abstract
Background: Extracorporeal photopheresis (ECP) is one of the most widely used and effective cell-based therapies for the treatment of T-cell-mediated diseases. The patients' white blood cells (WBCs) are collected by apheresis and exposed to the photosensitizer 8-methoxypsoralen (8-MOP) and ultraviolet A (UVA) light before retransfusion. The UVA/8-MOP combination has been in use in ECP for more than 4 decades; however, whether ECP can be simplified by UVA light irradiation only has never been analyzed.
Study design and methods: Peripheral blood mononuclear cells were treated with classical ECP or different UVA light doses only (UVAonly ). Treatment efficacy was investigated by apoptosis induction in WBC subsets, inhibition of T-cell proliferation, and the ability of monocytes to induce allogeneic T-cell expansion and to respond to lipopolysaccharide and interferon-γ stimulation in vitro.
Results: High-dose UVAonly treatment (5 J/cm2 ) was as efficient as ECP to induce apoptosis within 48 hours. UVAonly treatment modulated the composition of the surviving cells by improving monocyte survival and promoting CD8+ T-cell apoptosis. Both ECP and UVAonly treatment inhibited anti-CD3/anti-CD28 triggered T-cell proliferation. Interestingly, whereas ECP-treated monocytes exhibited a markedly reduced capacity to respond to stimulation and to induce allogeneic T-cell proliferation, UVAonly treatment preserved monocyte functionality to some degree.
Conclusions: High-dose UVAonly and standard ECP showed comparable efficacy in inducing apoptosis and inhibiting direct T-cell proliferation. Hence, UVAonly treatment can be a simplified alternative to ECP therapy. Furthermore, increased monocyte survival with partially preserved functionality after UVAonly treatment may provide a novel method for immunoregulation.
Keywords: UVA light; apoptosis; extracorporeal photopheresis.
© 2020 The Authors. Transfusion published by Wiley Periodicals LLC. on behalf of AABB.
Similar articles
-
Extracorporeal photochemotherapy induces bona fide immunogenic cell death.Cell Death Dis. 2019 Aug 2;10(8):578. doi: 10.1038/s41419-019-1819-3. Cell Death Dis. 2019. PMID: 31371700 Free PMC article.
-
In vitro treatment of monocytes with 8-methoxypsolaren and ultraviolet A light induces dendritic cells with a tolerogenic phenotype.Clin Exp Immunol. 2007 Jun;148(3):564-72. doi: 10.1111/j.1365-2249.2007.03372.x. Epub 2007 Mar 26. Clin Exp Immunol. 2007. PMID: 17386076 Free PMC article.
-
Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications.Transfusion. 2009 Nov;49(11):2366-73. doi: 10.1111/j.1537-2995.2009.02289.x. Transfusion. 2009. PMID: 19903292
-
Mechanisms of action of extracorporeal photochemotherapy.Transfus Apher Sci. 2003 Aug;29(1):61-70. doi: 10.1016/S1473-0502(03)00103-4. Transfus Apher Sci. 2003. PMID: 12877896 Review.
-
The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.Transfus Apher Sci. 2012 Apr;46(2):195-202. doi: 10.1016/j.transci.2011.10.016. Epub 2011 Nov 8. Transfus Apher Sci. 2012. PMID: 22067605 Review.
Cited by
-
Extracorporeal Photopheresis: Does It Have a Potential Place Among Cell-based Therapies?Transplant Direct. 2025 Sep 2;11(9):e1808. doi: 10.1097/TXD.0000000000001808. eCollection 2025 Sep. Transplant Direct. 2025. PMID: 40919458 Free PMC article.
-
Editorial: Community series in trends in neuroimmunology: cross-talk between brain-resident and peripheral immune cells in both health and disease, volume II.Front Immunol. 2025 Jul 3;16:1644278. doi: 10.3389/fimmu.2025.1644278. eCollection 2025. Front Immunol. 2025. PMID: 40677724 Free PMC article. No abstract available.
-
Extracorporeal photopheresis reduces the T cell stimulatory capacity of human primary blood conventional dendritic cells type 1.Front Immunol. 2025 Aug 13;16:1646421. doi: 10.3389/fimmu.2025.1646421. eCollection 2025. Front Immunol. 2025. PMID: 40881697 Free PMC article.
References
REFERENCES
-
- Edelson R, Berger C, Gasparro F, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med. 1987;316:297-303.
-
- Flowers ME, Apperley JF, van Besien K, et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood. 2008;112:2667-2674.
-
- Lamioni A, Parisi F, Isacchi G, et al. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation. 2005;79:846-850.
-
- Cho A, Jantschitsch C, Knobler R. Extracorporeal photopheresis-an overview. Front Med (Lausanne). 2018;5:236.
-
- Santella RM, Dharmaraja N, Gasparro FP, Edelson RL. Monoclonal antibodies to DNA modified by 8-methoxypsoralen and ultraviolet A light. Nucleic Acids Res. 1985;13:2533-2544.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials